Mycophenolate mofetil-induced villous atrophy

被引：66
|
作者：
Ducloux, D [1 ]
Ottignon, Y
Semhoun-Ducloux, S
Labbé, S
Saint-Hillier, Y
Miguet, JP
Carayon, P
Chalopin, JM
机构：
[1] CHU St Jacques, Dept Nephrol & Renal Transplantat, F-25000 Besancon, France
[2] CHU St Jacques, Dept Gastroenterol, F-25000 Besancon, France
[3] CHU St Jacques, Dept Hepatol, F-25000 Besancon, France
来源：
TRANSPLANTATION | 1998年 / 66卷 / 08期
关键词：
D O I：
10.1097/00007890-199810270-00027
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Mycophenolate mofetil (MMF) is a new immunosuppressant developed for the prevention and treatment of acute renal rejection after transplantation. Diarrhea is the most frequent side effect observed during treatment with MMF. Its pathogenic mechanisms remain unknown. We describe a case of severe diiarrhea due to villous atrophy in a renal transplant recipient during treatment with MMF. The patient was free of symptoms before MMF. Villous atrophy disappeared a few months after MMF withdrawal.
引用
收藏
页码：1115 / 1116
页数：2
相关论文
共 50 条
  • [21] Mycophenolate mofetil-induced colonic ulcerations in renal transplant patients
    Ali, T
    Sachdev, A
    Squires, RA
    Guild, RT
    Mesiya, SA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S199 - S200
  • [22] Mycophenolate mofetil-induced colonic ulceration in renal transplant recipients
    Golconda, MS
    Valente, JF
    Bejarano, P
    Gilinsky, N
    First, MR
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 272 - 273
  • [23] Characterization of mycophenolate mofetil-induced intestinal injury in transplant patients
    Heemskerk, L
    Gan, I
    Urbanski, S
    Falck, V
    McLaughlin, K
    Burak, KK
    Yilmaz, S
    Seminowich, S
    Martin, G
    Beck, PL
    GASTROENTEROLOGY, 2004, 126 (04) : A251 - A251
  • [24] Oral ulcerations in a renal transplant recipient: A mycophenolate mofetil-induced complication?
    Garrigue, V
    Canet, S
    Dereure, O
    Panabieres, O
    Augias, D
    Chong, G
    Mourad, G
    TRANSPLANTATION, 2001, 72 (05) : 968 - 969
  • [25] Mycophenolate mofetil-induced pseudotumor cerebri in a boy with autoimmune lymphoproliferative disease
    Turkan Patiroglu
    Alper Ozcan
    Musa Karakukcu
    Mehmet Akif Ozdemir
    Gamze Poyrazoglu
    Mehmet Canpolat
    Ekrem Unal
    Child's Nervous System, 2011, 27 : 853 - 855
  • [26] Mycophenolate mofetil-induced erythroid hypoplasia in a patient with systemic lupus erythematosus
    Doherty, T.
    Austin, S. K.
    Newell, B.
    Kiely, P. D. W.
    LUPUS, 2013, 22 (02) : 213 - 215
  • [27] Mycophenolate Mofetil-Induced Colonic Injury Manifesting Endoscopically As Ischemic Colitis
    Miranda, Clive J.
    Ali, Murad H.
    Ayaz, Muddasir
    Khan, Raheel M.
    Ismail, Mayada
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [28] Apoptosis and proliferation in mycophenolate mofetil-induced colitis and inflammatory bowel disease
    Delladetsima, I.
    Liapis, G.
    Boletis, J.
    Bamias, G.
    Tsimaratou, K.
    Patsouris, E.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 203 - 203
  • [29] Mycophenolate Mofetil-Induced Non-Healing Gastric and Duodenal Ulcers
    Chang, Vincent Chao
    Mai, Daniel
    Park, Michelle
    Lee, David P.
    Samarasena, Jason
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1089 - S1090
  • [30] Mycophenolate mofetil-induced pseudotumor cerebri in a boy with autoimmune lymphoproliferative disease
    Patiroglu, Turkan
    Ozcan, Alper
    Karakukcu, Musa
    Ozdemir, Mehmet Akif
    Poyrazoglu, Gamze
    Canpolat, Mehmet
    Unal, Ekrem
    CHILDS NERVOUS SYSTEM, 2011, 27 (05) : 853 - 855
12345